利多卡因与胺碘酮治疗急性心肌梗死后室性心律失常疗效分析

目的比较利多卡因与胺碘酮治疗急性心肌梗死后室性心律失常疗效。方法选取62例急性心肌梗死并发室性心律失常患者进行了临床研究，观察对象随机分成两组，其中32例给予利多卡因，30例使用胺碘酮。观察其对急性心肌梗死后室性心律失常的疗效、不良反应及短期预后。结果两种药物对室性心律失常的总有效率及1个月内死亡率差异无显著性，但胺碘酮治疗组不良反应发生率则高于利多卡因组，利多卡因转复心律失常的时间也明显短于胺碘酮组。结论心肌梗死急性期并发室性心律失常选用利多卡因可快速有效转复心律失常，且不良反应少。

Effects of lidocaine compared with amiodarone on ventricular arrhythmias after acute myocardial infarction

Objective To evaluate the efficacy of lidocaine and arniodarone on ventricular arrhythrnias after acute myocardial infarction. Methods Sixty - two patients were randomized to two groups. Among them, 32 patients were treated with lidocaine and 30 patients were treated with arniodarone. Then curative effects, adverse effects and monthly prognosis were observed during the therapeutic procedure. Results Both lidocaine and amiodarone have effects on ventricular arrhythrnias after acute myocardial infarction, there was no significant difference between two groups, and so monthly mortality. The incidence of adverse effects in arniodarone group was higher than that in lidocaine group. Conclusion Lidocaine can quickly and efficiently cure ventricular arrhythmias after acute myocardial infarction, and it has less adverse effects.